38 research outputs found

    A Novel Borna Disease Virus Vector System That Stably Expresses Foreign Proteins from an Intercistronic Noncoding Region▿

    Get PDF
    Borna disease virus (BDV), a nonsegmented, negative-strand RNA virus, infects a wide variety of mammalian species and readily establishes a long-lasting, persistent infection in brain cells. Therefore, this virus could be a promising candidate as a novel RNA virus vector enabling stable gene expression in the central nervous system (CNS). Previous studies demonstrated that the 5′ untranslated region of the genome is the only site for insertion and expression of a foreign gene. In this study, we established a novel BDV vector in which an additional transcription cassette has been inserted into an intercistronic noncoding region between the viral phosphoprotein (P) and matrix (M) genes. The recombinant BDV (rBDV) carrying green fluorescent protein (GFP) between the P and M genes, rBDV P/M-GFP, expressed GFP efficiently in cultured cells and rodent brains for a long period of time without attenuation. Furthermore, we generated a nonpropagating rBDV, ΔGLLP/M, which lacks the envelope glycoprotein (G) and a splicing intron within the polymerase gene (L), by the transcomplementation system with either transient or stable expression of the G gene. Interestingly, rBDV ΔGLLP/M established a persistent infection in cultured cells with stable expression of GFP in the absence of the expression of G. Using persistently infected rBDV ΔGLLP/M-infected cells, we determined the amino acid region in the cytoplasmic tail (CT) of BDV G important for the release of infectious rBDV particles and also demonstrated that the CT region may be critical for the generation of pseudotyped rBDV having vesicular stomatitis virus G protein. Our results revealed that the newly established BDV vector constitutes an alternative tool not only for stable expression of foreign genes in the CNS but also for understanding the mechanism of the release of enveloped virions

    Intensive Care and Vitamin D Status

    No full text
    Vitamin D has receptors in a vast majority of cells, and thus a normal vitamin D state is preferable to ensure an adequate function and appropriate response of the different receptors to a multitude of changes, namely, in critical illness. Vitamin D has many sources and exists in two different forms. Vitamin D state is divided into sufficient, insufficient, and deficient, and the variety in levels depends on plenty of factors, including the role of vitamin D-binding protein and possible influences from testing assays. Other possibilities that may take place in case of acute illness are also taken into consideration and discussed here. This chapter deals with the general aspects of vitamin D role in acute illness and how a replete state may affect the outcomes. The prevalence of vitamin D deficiency in critical illness and the frequency of testing and correction in case of deficiency are all considered here. ▶Chapter 67, “Specific Considerations Relevant to Critical Illness” by Dr. Amrein et al., discusses specific considerations of critical illness where vitamin D may have a role
    corecore